Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
10,417 results
- SuperShelfIndependent statistical analysis of A Multilevel Intervention in the Hunger Relief Network to Improve Diet Among Adults Experiencing Food Insecurity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Supplementation With Cholecalciferol in Dialysis Patients: Complete Statistical AnalysisIndependent statistical analysis of Supplementation With Cholecalciferol in Dialysis Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01974245).
- SUPPORTIndependent statistical analysis of A Study to Evaluate the Use of Mobile-phone Based Patient Support in Patients Diagnosed With Myocardial Infarction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Supported Employment in Patient Aligned Care Teams: Complete Statistical AnalysisIndependent statistical analysis of Supported Employment in Patient Aligned Care Teams: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02400736).
- Supporting Oral Pre-exposure Prophylaxis Decision Making Among Pregnant Women in Lilongwe, Malawi: Complete Statistical AnalysisIndependent statistical analysis of Supporting Oral Pre-exposure Prophylaxis Decision Making Among Pregnant Women in Lilongwe, Malawi: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Suppression Of Atrial Fibrillation With Ranolazine After Cardiac Surgery: Complete Statistical AnalysisIndependent statistical analysis of Suppression Of Atrial Fibrillation With Ranolazine After Cardiac Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01352416).
- Suppression of HIV 1 RNA in People Living With HIV: Complete Statistical AnalysisIndependent statistical analysis of Suppression of HIV 1 RNA in People Living With HIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02363387).
- Suprarenal Proximal Cuff Study for Treatment of Abdominal Aortic Aneurysm: Complete Statistical AnalysisIndependent statistical analysis of Suprarenal Proximal Cuff Study for Treatment of Abdominal Aortic Aneurysm: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00739401).
- SUPREMEIndependent statistical analysis of Sonendo GentleWave™ System for Treatment in Molar Teeth Requiring Root Canal Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SureshotIndependent statistical analysis of TRIGEN SURESHOT™ Distal Targeting System Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01327508).
- SURFAXIN® Treatment for Prevention of Bronchopulmonary Dysplasia (BPD) in Very Low Birth Weight (VLBW) Infants.: Complete Statistical AnalysisIndependent statistical analysis of SURFAXIN® Treatment for Prevention of Bronchopulmonary Dysplasia (BPD) in Very Low Birth Weight (VLBW) Infants.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Surgeon Experience ReSTOR A +4 Intraocular Lens (IOL): Complete Statistical AnalysisIndependent statistical analysis of Surgeon Experience ReSTOR A +4 Intraocular Lens (IOL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00733512).
- Surgeon Infiltration QL Block Comparison: Complete Statistical AnalysisIndependent statistical analysis of Surgeon Infiltration QL Block Comparison: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03496610).
- Surgery and Oxaliplatin or Mitomycin C in Treating Patients With Tumors of the Appendix: Complete Statistical AnalysisIndependent statistical analysis of Surgery and Oxaliplatin or Mitomycin C in Treating Patients With Tumors of the Appendix: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Surgical Site Infection With 0.05% Chlorhexidine (CHG) Compared to Triple Antibiotic Irrigation: Complete Statistical AnalysisIndependent statistical analysis of Surgical Site Infection With 0.05% Chlorhexidine (CHG) Compared to Triple Antibiotic Irrigation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Surgical Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen: Complete Statistical AnalysisIndependent statistical analysis of Surgical Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Surgical Trial Comparing LIGASURE Assisted Recto-Sigmoid Resection and Omentectomy Compared to Stand: Complete Statistical AnalysisIndependent statistical analysis of Surgical Trial Comparing LIGASURE Assisted Recto-Sigmoid Resection and Omentectomy Compared to Stand: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SURMOUNT-CNIndependent statistical analysis of A Study of Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- SURPASSIndependent statistical analysis of Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- SURPASS-6Independent statistical analysis of A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin: primary endpoint results,…
- SURPHIndependent statistical analysis of A Study of the Response to AG-86893 in Patients With Pterygium Hyperemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SURV1VEIndependent statistical analysis of SI + CC Versus 3:1 C:V Ratio During Neonatal CPR: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02858583).
- SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma: Complete Statistical AnalysisIndependent statistical analysis of SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Susceptibility of Motor-Evoked Potentials to Varying Targeted Blood Levels of Dexmedetomidine: Complete Statistical AnalysisIndependent statistical analysis of Susceptibility of Motor-Evoked Potentials to Varying Targeted Blood Levels of Dexmedetomidine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SUSTAINIndependent statistical analysis of Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes (SUSTAIN - CHINA MRCT): primary endpoint results, effect estimate…
- SUSTAIN™ 5Independent statistical analysis of Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 Diabetes: primary…
- Suvorexant and Trauma Related Insomnia: Complete Statistical AnalysisIndependent statistical analysis of Suvorexant and Trauma Related Insomnia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02704754).
- SWAP-ACIndependent statistical analysis of Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease: primary endpoint results, effect estimate with confidence interval,…
- SWARM-PaIndependent statistical analysis of Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis: primary endpoint results, effect estimate with confidence…
- SWEDESIndependent statistical analysis of Comparison Between Thrombolysis and Primary Percutaneous Coronary Intervention (PCI) to Treat ST-Segment Elevation Myocardial Infarction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- SweetDreams Sleep Study for Children With Autism: Complete Statistical AnalysisIndependent statistical analysis of SweetDreams Sleep Study for Children With Autism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04452045).
- SweetNalIndependent statistical analysis of Sweet Preference and Alcohol Craving: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01296646).
- SWIFTIndependent statistical analysis of Safety and Efficacy Study of Switching From Epzicom to Truvada: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00724711).
- SWIFTIndependent statistical analysis of SOLITAIRE™ FR With the Intention For Thrombectomy (SWIFT) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01054560).
- SWIFT-1Independent statistical analysis of Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SWIPEIndependent statistical analysis of Switch Maintenance Pembrolizumab in Patients With NSCLC After First Line Platinum Doublet Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SWITCHIndependent statistical analysis of Sleep Without Insomnia or The Use of Chronic Hypnotics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03687086).
- SWITCH 2Independent statistical analysis of A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes: primary endpoint results, effect estimate…
- SWITCH PROIndependent statistical analysis of A Research Study to Compare the Effect of Insulin Degludec and Insulin Glargine on Blood Sugar Levels in People With Type 2 Diabetes - the SWITCH PRO Study:…
- Switching From a Tenofovir Disoproxil Fumarate (TDF) Containing Regimen to Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Alafenamide (E/C/F/TAF) Fixed-Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Infected Adults Aged ≥ 60 Years: Complete Statistical AnalysisIndependent statistical analysis of Switching From a Tenofovir Disoproxil Fumarate (TDF) Containing Regimen to Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Alafenamide (E/C/F/TAF) Fixed-Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Infected Adults Aged ≥ 60 Years: primary endpoint…
- Sym004 in Patients With Advanced Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Sym004 in Patients With Advanced Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01117428).
- SYMPATICOIndependent statistical analysis of Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (MCL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SYMPHONY-2, A Trial to Examine Combination of Tazemetostat With Rituximab in Subjects With Relapsed/Refractory Follicular Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of SYMPHONY-2, A Trial to Examine Combination of Tazemetostat With Rituximab in Subjects With Relapsed/Refractory Follicular Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- SYMPHONYextIndependent statistical analysis of Clinical Study of Macitentan in Patients With PAH to Psychometrically Validate PAH-SYMPACT Instrument: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Symplicity AFIndependent statistical analysis of Renal Nerve Denervation in Patients With Hypertension and Paroxysmal and Persistent Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Symptoms-StepsIndependent statistical analysis of In Person and mHealth Coping Skills Training for Symptom Management and Steps in Stem Cell Transplant Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Synagis RussiaIndependent statistical analysis of A Study to Assess the Safety and Effectiveness of Palivizumab Administered to Children at High Risk of Severe Respiratory Syncytial Virus (RSV) Infection in the Russian Federation and…
- Systemic Chemotherapy and Subtenon Carboplatin, and Local Ophthalmic Therapy in Children With Intraocular Retinoblastoma: Complete Statistical AnalysisIndependent statistical analysis of Systemic Chemotherapy and Subtenon Carboplatin, and Local Ophthalmic Therapy in Children With Intraocular Retinoblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Systemic Immunomodulatory Effects and Pharmacogenetics of Atorvastatin in Early Atherosclerosis: Complete Statistical AnalysisIndependent statistical analysis of Systemic Immunomodulatory Effects and Pharmacogenetics of Atorvastatin in Early Atherosclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00361283).
- Systemic Pharmacokinetics Following Intravitreal Injections of Anti-VEGF: Complete Statistical AnalysisIndependent statistical analysis of Systemic Pharmacokinetics Following Intravitreal Injections of Anti-VEGF: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02118831).